Lakshmi Rajdev is an Oncology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 119 publications with 2,330 citations (h-index 23); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Weiler - Dept. Of Oncology
1695 Eastchester Road
Bronx, NY 10461
Telephone
718-405-8505Registry record last updated 5 Jan 2012.
Clinical trials
- Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
Sponsor: National Cancer Institute (NCI)
- Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Sponsor: National Cancer Institute (NCI)
- Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BeOne Medicines USA, Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56.7%Serotonin-3 Receptor Antagonist23.4%Ondansetron Odt100%Part D≥12 patientsOpioid Agonist21.3%Loperamide100%Part D≥12 patients+ 1 more class in this area
Nervous system
27%Phenothiazine19.1%Prochlorperazine Maleate100%Part D≥12 patientsOpioid Agonist7.8%Oxycodone-Acetaminophen100%Part D<11 patientsCardiovascular
16.3%Antiarrhythmic16.3%Lidocaine-Prilocaine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline
Journal of Clinical Oncology
2024 - Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Journal of Clinical Oncology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”